ATE239016T1 - Verfahren zur herstellung von einer nicht- kristallinen wasswerfreien form von paroxetin hydrochlorid - Google Patents

Verfahren zur herstellung von einer nicht- kristallinen wasswerfreien form von paroxetin hydrochlorid

Info

Publication number
ATE239016T1
ATE239016T1 AT99940290T AT99940290T ATE239016T1 AT E239016 T1 ATE239016 T1 AT E239016T1 AT 99940290 T AT99940290 T AT 99940290T AT 99940290 T AT99940290 T AT 99940290T AT E239016 T1 ATE239016 T1 AT E239016T1
Authority
AT
Austria
Prior art keywords
producing
anhydrous form
paroxetine hydrochloride
crystalline anhydrous
crystalline
Prior art date
Application number
AT99940290T
Other languages
English (en)
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817196.0A external-priority patent/GB9817196D0/en
Priority claimed from GBGB9828777.4A external-priority patent/GB9828777D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE239016T1 publication Critical patent/ATE239016T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99940290T 1998-08-07 1999-08-06 Verfahren zur herstellung von einer nicht- kristallinen wasswerfreien form von paroxetin hydrochlorid ATE239016T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817196.0A GB9817196D0 (en) 1998-08-07 1998-08-07 Novel process
GBGB9828777.4A GB9828777D0 (en) 1998-12-29 1998-12-29 Novel compounds
PCT/GB1999/002592 WO2000008017A1 (en) 1998-08-07 1999-08-06 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride

Publications (1)

Publication Number Publication Date
ATE239016T1 true ATE239016T1 (de) 2003-05-15

Family

ID=26314179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99940290T ATE239016T1 (de) 1998-08-07 1999-08-06 Verfahren zur herstellung von einer nicht- kristallinen wasswerfreien form von paroxetin hydrochlorid

Country Status (23)

Country Link
EP (2) EP1321465A3 (de)
JP (1) JP2002522434A (de)
KR (1) KR20010072323A (de)
CN (1) CN1321155A (de)
AP (2) AP0102072A0 (de)
AT (1) ATE239016T1 (de)
AU (1) AU5428999A (de)
BG (1) BG105310A (de)
BR (1) BR9912858A (de)
CA (1) CA2339857A1 (de)
DE (1) DE69907467T2 (de)
DK (1) DK1100796T3 (de)
EA (1) EA200100221A1 (de)
ES (1) ES2198940T3 (de)
HU (1) HUP0105466A3 (de)
ID (1) ID27914A (de)
IL (1) IL141286A0 (de)
NO (1) NO20010629L (de)
PL (1) PL345885A1 (de)
PT (1) PT1100796E (de)
SK (1) SK1972001A3 (de)
TR (1) TR200100444T2 (de)
WO (1) WO2000008017A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384720A1 (de) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Verfahren zur Trocknung von Paroxetinhydrochlorid
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
WO2002040508A2 (en) * 2000-11-17 2002-05-23 Eli Lilly And Company Lactam dipeptide and its use in inhibiting beta-amyloid peptide release
WO2004035052A1 (ja) 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited 安定な固形製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
AU730532B2 (en) * 1997-01-15 2001-03-08 Smithkline Beecham Plc Paroxetine compositions
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法

Also Published As

Publication number Publication date
CN1321155A (zh) 2001-11-07
TR200100444T2 (tr) 2001-07-23
PT1100796E (pt) 2003-09-30
DE69907467T2 (de) 2004-03-11
KR20010072323A (ko) 2001-07-31
ID27914A (id) 2001-05-03
NO20010629L (no) 2001-03-20
EP1100796A1 (de) 2001-05-23
HK1038230A1 (en) 2002-03-08
CA2339857A1 (en) 2000-02-17
EA200100221A1 (ru) 2001-08-27
EP1321465A2 (de) 2003-06-25
PL345885A1 (en) 2002-01-14
ES2198940T3 (es) 2004-02-01
AP0102072A0 (en) 2001-02-06
SK1972001A3 (en) 2001-08-06
HUP0105466A3 (en) 2002-11-28
EP1321465A3 (de) 2003-09-03
NO20010629D0 (no) 2001-02-06
HUP0105466A2 (hu) 2002-05-29
IL141286A0 (en) 2002-03-10
BG105310A (en) 2001-12-29
EP1100796B1 (de) 2003-05-02
DE69907467D1 (de) 2003-06-05
AU5428999A (en) 2000-02-28
JP2002522434A (ja) 2002-07-23
BR9912858A (pt) 2001-11-20
AP2001002072A0 (en) 2001-03-31
DK1100796T3 (da) 2003-08-25
WO2000008017A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
DE69631298D1 (de) Verfahren zur Herstellung von Paroxetinhydrochloridanhydrat
DE60008136D1 (de) Verbessertes verfahren zur herstellung von n-substituierte aminotetraline
DE60030949D1 (de) Verfahren zur herstellung einer karte
DE60125755D1 (de) Verfahren zur herstellung einer flexodruckplatte
ATE247627T1 (de) Verfahren zur herstellung nicht-hygroscopische l (-) - carnitine salze
DE69906491D1 (de) VERFAHREN ZUR HERSTELLUNG EINER SiCOI-STRUKTUR
DE69841475D1 (de) Verfahren zur Herstellung eines MOSFET
DE69840399D1 (de) Verfahren zur Herstellung einer Gate-Elektrode
DE69911404D1 (de) Verfahren zur herstellen einer hülse
DE69919412D1 (de) Verfahren zur herstellung von polyolefine
ATE249417T1 (de) Verfahren zur herstellung von l- phenylephrinhydrochlorid
DE69840320D1 (de) Verfahren zur Herstellung einer Gateelektrode
ATE221050T1 (de) Verfahren zur herstellung von lercanidipin hydrochlorid
ATE297379T1 (de) Verfahren zur herstellung eines geschützten 4- aminomethyl-pyrrolidin-3-ons
DE50009805D1 (de) Verfahren zur herstellung einer torsionsfeder
ATE291356T1 (de) Verfahren zur herstellung einer aromazusammensetzung auf pilzbasis
DE69919408D1 (de) Verfahren zur herstellung von polyolefine
DE60003264D1 (de) Verfahren zur herstellung von glycerylethern
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
DE69616543D1 (de) Verfahren zur herstellung von ropivacainehydrochlorid-monohydrat
ATE234269T1 (de) Verfahren zur herstellung von cis-1-2-(4-(6-
ATE239016T1 (de) Verfahren zur herstellung von einer nicht- kristallinen wasswerfreien form von paroxetin hydrochlorid
DE60128544D1 (de) Verfahren zur herstellung einer siliziumschmelze
DE60114214D1 (de) Verfahren zur herstellung einer zahnbürste
DE50113402D1 (de) Verfahren zur Herstellung einer Hochspannungsdurchführung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1100796

Country of ref document: EP

REN Ceased due to non-payment of the annual fee